USPTO serial 90021228
V-LK
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 28, 2021
- Examiner
- BEGGS, MONICA L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with V-LK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Vetter Pharma-Fertigung GmbH & Co. KG
Ravensburg, DE
Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
Vetter Pharma-Fertigung GmbH & Co. KG
Ravensburg, DE
Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
Vetter Pharma-Fertigung GmbH & Co. KG
Ravensburg, DE
Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
M. Scott Alprin
M. Scott Alprin ALPRIN LAW OFFICES, P.C.5 PINEHURST CIRCLE, N.W.WASHINGTON, DC 20015UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Prefilled syringes, double chamber syringes and injection pens with solid, semisolid, or liquid pharmaceutical substances for use in treating infections, cancer, depression, heart disease, vascular disease, intestinal disorders, lung and bronchial dysfunction, liver dysfunction, oral and laryngeal disease, optical and cranial disorders | ACTIVE | — |
| 010 | Syringes, double chamber syringes and double chamber cartridges for medical use sold empty, namely, for medical use in treating infections, cancer, depression, heart disease, vascular disease, intestinal disorders, lung and bronchial dysfunction, liver dysfunction, oral and laryngeal disease, optical and cranial disorders and parts of said goods, namely, caps, protection caps, flexible sealings and flat cylindrical sealing rings | ACTIVE | — |
| 039 | Aseptic, sterile bottling of substances, namely, pharmaceutical, chemical and biological preparations and medicines | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
- Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
- Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 039
- Similar marks named V-LK
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 28, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 28, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 13, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 13, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 23, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 5, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 29, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 29, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 28, 2021 | ALIE | ASSIGNED TO LIE | — |
| Mar 2, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 28, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 28, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 28, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 23, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 29, 2020 | NWAP | NEW APPLICATION ENTERED | — |